Literature DB >> 24872510

Influence of stromal-epithelial interactions on androgen action.

Cera M Nieto1, Leah C Rider1, Scott D Cramer2.   

Abstract

Androgen receptor (AR) signaling is vital to the development and function of the prostate and is a key pathway in prostate cancer. AR is differentially expressed in the stroma and epithelium, with both paracrine and autocrine control throughout the prostate. Stromal-epithelial interactions within the prostate are commonly dependent on AR signaling and expression. Alterations in these pathways can promote tumorigenesis. AR is also expressed in normal and malignant mammary tissues. Emerging data indicate a role for AR in certain subtypes of breast cancer that has the potential to be exploited therapeutically. The aim of this review is to highlight the importance of these interactions in normal development and tumorigenesis, with a focus on the prostate and breast.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  androgen receptor; androgens; breast; prostate

Mesh:

Substances:

Year:  2014        PMID: 24872510     DOI: 10.1530/ERC-14-0138

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  14 in total

Review 1.  The role of the prostate in male fertility, health and disease.

Authors:  Paolo Verze; Tommaso Cai; Stefano Lorenzetti
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

2.  Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.

Authors:  Steve Paltoglou; Rajdeep Das; Scott L Townley; Theresa E Hickey; Gerard A Tarulli; Isabel Coutinho; Rayzel Fernandes; Adrienne R Hanson; Iza Denis; Jason S Carroll; Scott M Dehm; Ganesh V Raj; Stephen R Plymate; Wayne D Tilley; Luke A Selth
Journal:  Cancer Res       Date:  2017-05-04       Impact factor: 12.701

Review 3.  The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?

Authors:  Carole Luthold; Tarek Hallal; David P Labbé; François Bordeleau
Journal:  Cancers (Basel)       Date:  2022-06-11       Impact factor: 6.575

Review 4.  Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.

Authors:  Sujata Narayanan; Sandy Srinivas; David Feldman
Journal:  Nat Rev Urol       Date:  2015-12-08       Impact factor: 14.432

Review 5.  Telomeres and telomerase in prostate cancer development and therapy.

Authors:  Mindy Kim Graham; Alan Meeker
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

Review 6.  Stromal Androgen Receptor in Prostate Cancer Development and Progression.

Authors:  Damien A Leach; Grant Buchanan
Journal:  Cancers (Basel)       Date:  2017-01-22       Impact factor: 6.639

7.  Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.

Authors:  Emma H Allott; Elizabeth M Masko; Alexis R Freedland; Everardo Macias; Kristine Pelton; Keith R Solomon; Elahe A Mostaghel; George V Thomas; Salvatore V Pizzo; Michael R Freeman; Stephen J Freedland
Journal:  Prostate Cancer Prostatic Dis       Date:  2018-05-23       Impact factor: 5.554

Review 8.  Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast Carcinogenesis.

Authors:  Madalin Marius Margan; Andreea Adriana Jitariu; Anca Maria Cimpean; Cristian Nica; Marius Raica
Journal:  J Breast Cancer       Date:  2016-06-24       Impact factor: 3.588

9.  The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.

Authors:  Emuejevoke Olokpa; Adrienne Bolden; LaMonica V Stewart
Journal:  J Cell Physiol       Date:  2016-03-14       Impact factor: 6.384

Review 10.  Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.

Authors:  Osama S Mohammad; Michael D Nyquist; Michael T Schweizer; Stephen P Balk; Eva Corey; Stephen Plymate; Peter S Nelson; Elahe A Mostaghel
Journal:  Cancers (Basel)       Date:  2017-12-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.